Related Experiment Video
Updated: Nov 21, 2025

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Restoring ventricular restoration: A call to re-evaluate a surgical therapy considered ineffective
Torsten Doenst1, Eric J Velazquez2, Robert E Michler3
1Department of Cardiothoracic Surgery, Friedrich-Schiller-University of Jena, University Hospital Jena, Jena, Germany.
Insights
Surgical restoration of postischemically dilated left ventricles (SVR) is under scrutiny after the STICH trial. A new analysis aims to re-evaluate SVR
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Outcomes
- Ischemic Heart Disease Management
Background:
- The Surgical Treatment of IsChemic Heart failure (STICH) Trial reported no benefit for surgical restoration of postischemically dilated left ventricles (SVR) in patients with coronary artery disease (CAD) and low ejection fraction.
- Criticism suggests the STICH trial's patient selection and surgical expertise may have limited its ability to assess SVR's true potential, particularly in aneurysm patients.
Purpose of the Study:
- To address the controversy surrounding the STICH trial's findings on SVR.
- To propose and justify a new analysis comparing STICH patients with a cohort of SVR patients treated by an expert center.
Main Methods:
- The proposed study will compare the patient population from the STICH trial with a comparable group of SVR patients.
- The comparison group will consist of patients treated at a center with documented expertise in SVR.
Main Results:
- The abstract does not contain specific results, but discusses the rationale for a future analysis.
Conclusions:
- The proposed comparative analysis has the potential to provide valuable insights into the efficacy of SVR.
- Re-evaluating SVR with improved patient selection and surgical expertise may clarify its role in treating ischemic heart failure.
Abstract:
The technique of surgical restoration of postischemically dilated left ventricles (SVR) has almost disappeared from operating theaters after the Surgical Treatment of IsChemic Heart failure (STICH) Trial demonstrated no treatment effect in patients with CAD and ejection fraction below 35%. Criticism on the trial was expressed stating that surgical expertise and patient selection (i.e., almost no aneurysm patients included) may have been inadequate to test the procedure s potential. Gaudino and colleagues now propose to conduct an analysis comparing the STICH patient population to a group of comparable SVR patients treated by a center with documented specific expertise for this technique. We here address the background of the trial and the following controversy and suggest a rationale why the suggested analysis has the potential to add valuable information to the field.
More Related Videos
14:14Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Aortic Regurgitation III: Medical Management
Heart Failure VI: Adjunct Therapies
Endocarditis III: Medical Management